(Q42275878)

English

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial

scientific article published on 7 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial (English)

1 reference

Europe PubMed Central

19 October 2017

phase II clinical trial

0 references

hospitalization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Christopher Lucasti

1

1 reference

Europe PubMed Central

19 October 2017

Irinel Popescu

2

1 reference

Europe PubMed Central

19 October 2017

Mayakonda K Ramesh

3

1 reference

Europe PubMed Central

19 October 2017

Joy Lipka

4

1 reference

Europe PubMed Central

19 October 2017

Carole Sable

5

1 reference

Europe PubMed Central

19 October 2017

language of work or name

0 references

publication date

7 February 2013

1 reference

Europe PubMed Central

19 October 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

19 October 2017

68

1 reference

Europe PubMed Central

19 October 2017

5

1 reference

Europe PubMed Central

19 October 2017

1183-1192

1 reference

Europe PubMed Central

19 October 2017

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

In vitro activity of ceftazidime combined with NXL104 versus Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals (CANWARD 2009 study).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Anti

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Antibiotic susceptibility of intra-abdominal infection isolates from Indian hospitals during 2008.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Re

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS523

21 January 2018

Identifiers

10.1093/JAC/DKS523

1 reference

Europe PubMed Central

19 October 2017

release_rn3n6wv3lzh4nba3itcvxyywau

1 reference

https://api.fatcat.wiki/v0/release/rn3n6wv3lzh4nba3itcvxyywau

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42275878&oldid=1940919417"